Literature DB >> 11390861

Adrenomedullin: Is There Physiological Relevance in the Pathology and Pharmacology?

Willis K. Samson1, Zachary T. Resch, Tonya C. Murphy, Trini T. Vargas, Debra A. Schell.   

Abstract

The adrenomedullin gene encodes two potent hypotensive peptides, adrenomedullin and proadrenomedullin NH(2)-terminal 20 peptide. As with other vasoactive peptides, the most difficult challenge is to prove the physiological relevance of their recognized pathological and pharmacological actions and to establish, against that physiological background, their therapeutic potential.

Entities:  

Year:  1999        PMID: 11390861     DOI: 10.1152/physiologyonline.1999.14.6.255

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN: 0886-1714


  4 in total

1.  Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1.

Authors:  Shaolong Yang; Mian Zhou; Irshad H Chaudry; Ping Wang
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care.

Authors:  Oscar H M Lundberg; Mari Rosenqvist; Kevin Bronton; Janin Schulte; Hans Friberg; Olle Melander
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

3.  Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.

Authors:  Oscar H M Lundberg; Lill Bergenzaun; Jörgen Rydén; Mari Rosenqvist; Olle Melander; Michelle S Chew
Journal:  Crit Care       Date:  2016-06-09       Impact factor: 9.097

4.  Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.

Authors:  Oscar H M Lundberg; Maria Lengquist; Martin Spångfors; Martin Annborn; Deborah Bergmann; Janin Schulte; Helena Levin; Olle Melander; Attila Frigyesi; Hans Friberg
Journal:  Crit Care       Date:  2020-11-04       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.